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Abstract 
Objective: Malignant pleural mesothelioma is a global health issue. Arsenic trioxide (ATO) has been shown to suppress thymidylate 
synthase (TYMS) in colorectal cancer (decrease cell growth) and induce apoptosis (cell death) in blood cancer. The effect of ATO in 
mesothelioma was therefore studied. 
Materials and methods: A panel of 5 mesothelioma cell lines was used to study the effect of ATO on cell viability, TYMS protein 
expression and TYMS activity. Alteration of apoptotic/anti-apoptotic proteins induced by ATO was explored. The effect of ATO was 
also studied using a mice model. 
Results: Application of ATO demonstrated anti-cancer effects in the cell line model with clinically achievable concentrations. 
Downregulation of TYMS protein and TYMS activity were also observed. The expression of anti-apoptotic factors were decreased 
while apoptotic factors were increased so as apoptosis was induced. In mice model, the relative tumor volumes were reduced in the 
ATO treatment group. 
Conclusion: ATO has potent antiproliferative and cytotoxic effects in mesothelioma by TYMS downregulation and apoptosis. There 
is sound scientific evidence to support the clinical application of ATO in treatment of mesothelioma. 
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